TRO40303, a mitochondrial-targeted cytoprotective compound, provides protection in hepatitis models

Por Schaller, Sophie, Michaud, Magali, Latyszenok, Virginie, Robert, Fabrice, Hocine, Mélanie, Arnoux, Thomas, Gabriac, Mélanie, Codoul, Hélène, Bourhane, Ahmed, de Bellefois, Isabel Clémançon, Afxantidis, Jean, Pruss, Rebecca M
Publicado no Pharmacol Res Perspect (2015)

Translation of TRO40303 from myocardial infarction models to demonstration of safety and tolerance in a randomized Phase I trial

Por Le Lamer, Sophie, Paradis, Stéphanie, Rahmouni, Hidayat, Chaimbault, Corinne, Michaud, Magali, Culcasi, Marcel, Afxantidis, Jean, Latreille, Mathilde, Berna, Patrick, Berdeaux, Alain, Pietri, Sylvia, Morin, Didier, Donazzolo, Yves, Abitbol, Jean-Louis, Pruss, Rebacca M, Schaller, Sophie
Publicado em 2014